Is silver nitrate pleurodesis for patients with malignant pleural effusion feasible and safe when performed in an outpatient setting?

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 1145-1150

  Terra, Ricardo Mingarini ^a   Kim, So Yeon ^a   Pego Fernandes, Paulo Manuel ^a   Teixeira, Lisete Ribeiro ^a   Vargas, Francisco Suso ^a   Jatene, Fabio Biscegli ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

SILVER NITRATE;

ADULT; AMBULATORY SURGERY; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURODESIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; QUALITY OF LIFE; RECURRENT MALIGNANT PLEURAL EFFUSION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PROSPECTIVE STUDIES; RECURRENCE; SILVER NITRATE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955852774     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1447-8     Document Type: Article

References (27)

1. Lynch TJ Jr. Management of malignant pleural effusions. Chest. 1993;103:385S-9S. (Pubitemid 23110360)
2. Neto JD, de Oliveira SF, Vianna SP, Terra RM. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions. Respirology. 2010;15:115-8.
3. de Campos JR, Vargas FS, de Campos Werebe E, Cardoso P, Teixeira LR, Jatene FB, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119:801-6. (Pubitemid 32197651)
4. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120: 56-64. (Pubitemid 24011502)
5. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions (Cochrane Review). In: The Cochrane Library. Issue 4, 2004. Oxford: Updated Software.
6. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest. 1994;106:342-6. (Pubitemid 24252022)
7. Werebe EC, Pazetti R, Milanez de Campos JR, Fernandez PP, Capelozzi VL, Jatene FB, Vargas FS. Systemic distribution of talc after intrapleural administration in rats. Chest. 1999;115: 190-93. (Pubitemid 29047074)
8. de Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997;349:251.
9. Rehse DH, Aye RW, Florence MG. Respiratory failure after talc pleurodesis. Am J Surg. 1999;177:437-40.
10. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369:1535-9. (Pubitemid 46670303)
11. Genofre EH, Vargas FS, Acencio MM, Antonangelo L, Teixeira LR, Marchi E. Talc pleurodesis: evidence of systemic inflammatory response to small size talc particles. Respir Med. 2009; 103:91-7.
12. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170:377-82. (Pubitemid 39214610)
13. Ferrer J, Montes JF, Villarino MA, Light RW, Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest. 2002;122:1018-27.
14. Paschoalini M da S, Vargas FS, Marchi E, Pereira JR, Jatene FB, Antonangelo L, et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest. 2005;128:684-9. (Pubitemid 41140496)
15. Vargas FS, Teixeira LR, Vaz MA, Carmo AO, Marchi E, Cury PM, et al. Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits. Chest. 2000;118:808-13.
16. Saffran L, Ost DE, Fein AM, Schiff MJ. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest. 2000;118:417-21. (Pubitemid 30637809)
17. Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest. 2003;123:1895-8. (Pubitemid 36706709)
18. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003 (http://ctep.cancer.gov), Publish Date: August 9, 2006.
19. The WHOQoL Group. The development of the World Health Organization quality of life assessment instrument (the WHOQoL). In: Orley J, Kuyken W, eds. Quality of Life Assessment: International Perspectives. Heidelberg: Springer Verlag, 1994.
20. Fleck MPA, Leal OF, Louzada S, Xavier M, Chachamovich E, Vieira G, et al. Desenvolvimento da versão em português do instrumento de avaliação de qualidade de vida da OMS (WHOQoL-100) 1999. Rev Bras Psiquiatr. 1999;21:19-28.
21. Wied U, Andersen K, Schultz A, Rasmussen E, Watt-Boolsen S. Silver nitrate pleurodesis in spontaneous pneumothorax. Scand J Thorac Cardiovasc Surg. 1981;15:305-7. (Pubitemid 12242359)
22. Wied U, Halkier E, Hoeier-Madsen K, Plucnar B, Rasmussen E, Sparup J. Tetracycline versus silver nitrate pleurodesis in spontaneous pneumothorax. J Thorac Cardiovasc Surg. 1983;86: 591-3.
23. Vargas FS, Teixeira LR, Silva LM, Carmo AO, Light RW. Comparison of silver nitrate and tetracycline as pleural sclerosing agents in rabbits. Chest. 1995;108:1080-3.
24. Vargas FS, Antonangelo L, Capelozzi V, Vaz MA, Genofre EH, Marchi E, et al. Lung damage in experimental pleurodesis induced by silver nitrate or talc: 1-year follow-up. Chest. 2002;122: 2122-6. (Pubitemid 36051152)
25. Terra RM, Teixeira LR, Bibas BJ, Pego-Fernandes PM, Vargas FS, Jatene FB. Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status. Clinics. 2011 [Epub ahead of print].
26. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129:362-8. (Pubitemid 43289856)
27. Warren WH, Kim AW, Liptay MJ. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg. 2008;33:89-94. (Pubitemid 350266354)